Purification and characterization of a high-molecular-weight endogenous glutamate-binding inhibitor in porcine brain
- 1 October 1994
- journal article
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 1 (4) , 245-252
- https://doi.org/10.1007/bf02253309
Abstract
A high-molecular-weight glutamate-binding inhibitor (HGBI) from porcine brain extract was purified to homogeneity. The results of this purification process show that glutamate receptor activity can be regulated by a high-molecular-weight protein, which inhibits [3H]L-glutamate binding to excitatory amino acid (EAA) receptors. The purified HGBI appears to be a protein with a molecular weight of approximately 70 kD. The purified HGBI is negatively charged, suggesting that it may contain acidic amino acids, and most likely,L-glutamate- andL-aspartate-enriched regions, responsible for its surface charge as well as for its binding to glutamate receptors. Inhibition of [3H]L-glutamate binding by the purified HGBI is reversible, and appears to change the binding kinetics. This endogenous ligand for glutamate receptors has unique characteristics separating it from all the other ligands found so far in the EAA receptor system. This HGBI represents a new class of modulator for the EAA receptor, thus further investigation of the function and structure of the HGBI should provide new understanding of the mechanisms of EAA-mediated neurotransmission.Keywords
This publication has 29 references indexed in Scilit:
- Alternative molecular interpretations of binding curves: compelling competition?Trends in Pharmacological Sciences, 1987
- Localization of N-acetylaspartylglutamate-like immunoreactivity in selected areas of the rat brainNeuroscience Letters, 1986
- Effects of excitatory amino acid antagonists on evoked and spontaneous excitatory potentials in guinea‐pig hippocampus.The Journal of Physiology, 1986
- Kynurenic acid distinguishes kainate and quisqualate receptors in the vertebrate retinaBrain Research, 1986
- Replication of the neurochemical characteristics of Huntington's disease by quinolinic acidNature, 1986
- Excitatory amino acid synaptic mechanisms and neurological functionTrends in Pharmacological Sciences, 1986
- A brain octadecaneuropeptide generated by tryptic digestion of DBI (diazepam binding inhibitor) functions as a proconflict ligand of benzodiazepine recognition sitesNeuropharmacology, 1984
- Characterization of Two [3H]Glutamate Binding Sites in Rat Hippocampal MembranesJournal of Neurochemistry, 1981
- Identification of inosine and hypoxanthine as endogenous ligands for the brain benzodiazepine-binding sites.Proceedings of the National Academy of Sciences, 1979
- HIGH AFFINITY l‐[3H]GLUTAMATE BINDING TO POSTSYNAPTIC RECEPTOR SITES ON RAT CEREBELLAR MEMBRANESJournal of Neurochemistry, 1978